Sustainability leadership SEKISUI Diagnostics has multiple sustainability accolades including EcoVadis Silver medals for 2025, signaling strong ESG credentials which can be leveraged to win bids that require sustainability compliance and responsible sourcing.

Expansion footprint Recent investments to expand cGMP microbial capacity in the UK and Europe, plus multi-country manufacturing and R&D presence, create opportunities for regional supply continuity, faster lead times, and co-development programs with healthcare providers.

RSV and infectious disease focus Launch of OSOM RSV and rapid infectious disease testing tools positions the company as a go-to partner for point-of-care and rapid diagnostics, suggesting sales potential in hospitals, clinics, and urgent care networks seeking rapid RSV solutions.

Strategic partnerships collaborations with PEI BioAlliance and Microbix Biosystems indicate strong channel and co-development potential, enabling joint marketing, distribution expansion, and access to broader scientific talent pools.

High-throughput and automation A leading position in high throughput coagulation systems in Japan and automated systems alongside reagents for clinical chemistry and enzymes implies opportunities to upsell integrated laboratory automation, reagents, and modular diagnostic workflows to mid-to-large laboratories.